Materials and Methods contained two principal objectives : first, to determine whether injections of mAbs would in fact be useful for the prevention of BB/Wor diabetes; second, if we were successful in achieving our first objective, to identify the lymphocyte subset(s) that mediate pancreatic ,# cell destruction .
We report here that (a) phenotypic OX19-reactive lymphocytes (all T cells) and OX8-cells (cytotoxic/suppressor and NK cells) were selectively depleted from adult BB/Wor rats by prolonged injections of tissue culture supernatants (TCS) containing OX 19 or OX8 mAbs; (b) NK lytic activity was significantly reduced in OX8-depleted animals ; (c) rats treated with either OX8 or OX19 TCS were protected against the occurrence of diabetes . We conclude that the subsets of rat lymphocytes that express OX8 and OX 19 surface antigens participate in BB/Wor pancreatic (3 cell destruction .
Animals. Intact litters of diabetes-prone (DB-PRN) BB/Wor rats, 25-35 d ofage, were obtained from the breeding colony maintained at the University of Massachusetts Medical School . Animals in the 17-21st generation of brother X sister matings, with an expected diabetes frequency of 40-80% were housed under specific pathogen-free (SPF) barrier conditions wherein they received laboratory chow and water ad libitum. All animals were tested for glycosuria three times weekly. Rats were considered diabetic if urine glucose was 2-4+ with TesTape and plasma glucose values (Beckman Instruments, Fullerton, CA) exceeded 200 mg/dl.
Antibodies . MRC OX6, OX8, OX17, OX19, W3/13, W3/25, OX35, OX38, and OX52 mAb were produced by hybridoma cell lines obtained from Drs . A. F. Williams and D. W. Mason, Oxford University (Oxford, United Kingdom) (21) (22) (23) . 3JP producing cells were received from Dr. Charles Janeway, Yale University (New Haven, CT) . The isotypes and reactivity of these mAbs are listed in Table I . The hybridoma cell lines were cultured under standard tissue culture conditions, and the undiluted mAbs containing TCS were stored at -20'C until the time for injection or use in the identification of lymphocyte cell type by flow cytometry. Although the mAb concentrations in the TCS were not quantified, each lot of TCS produced was tested by flow cytometry with normal rat spleen cells to insure the presence ofsaturating concentrations of the specific antibody . Fluoresceinated F(ab')z goat anti-mouse IgG (H and L chains), absorbed to remove crossreactivity with rat IgG, was obtained from Cappel Laboratories, Cochranville, PA. Chromium-release Cytotoxicity Assay. Microcytotoxicity assays were carried out as described (27) . YAC-1, a cell line extremely sensitive to lysis mediated by NK cells (28) , was labelled with Na 5 'Cr (Amersham Corp ., Arlington Heights, IL) for use as target cells . Effector cells were splenic mononuclear cells . Three or more E/T ratios ranging from 200 :1 to 3 :1 were tested on microtiter plates with 104 target cells/well . Medium was added to target cells for spontaneous lysis determinations, and 1 % NP-40 was added for determination of 100% lysis . Assays were incubated for 4-6 h in a humidified 37°C, 5% CO Z in air incubator. Plates were centrifuged before harvest, and one-half of the supernatant fluid collected for radioactive counting in a Beckman gamma 5500 counter, (Beckman Instruments, Palo Alto, CA) . The quadruplicate samples had standard deviations of <5% of the mean . Spontaneous release in different assays ranged from 5 to 12% . The data were derived from aglycosuric animals sacrificed after 5, 9, and 14 wk of TCS injections . The splenic lymphocyte subsets were similar at each time point, and were therefore pooled. * p < 0 .05 for OX 19 treatment vs. all other groups. SNK and LSD with BFA . p < 0 .001 for OX 19 vs . all other groups (except W3/25 One-way analyses of variance were used to compare the effects of the various treatment regimens on splenic and peripheral lymphocyte subsets . Individual pairs of groups were compared using a Student-Newman-Keuls (SNK) as well as a Fisher's least significant difference (LSD) Test with a Bonferonni adjustment (BFA) to compensate for additive type I errors. The effects of treatment on the frequency of diabetes, insulitis, and thyroiditis were analyzed using Fisher's exact test with BFA. Cytotoxicity data were analyzed using a student's t test. The effects of OX8 and OX19 treatment on autoantibody frequency were compared with the Fisher's exact test.
Results
Effects of Antibody Injections on Lymphocyte Subsets . Splenic lymphocyte subsets of uninjected diabetes-prone rats revealed the anticipated profound T lymphopenia and reduced percentages of W3/25 and OX8 subsets (Table II) (26, (29) (30) (31) . OX6-staining B lymphocytes were reciprocally increased . Injections of TCS containing OX 19 mAb significantly reduced the mean percentage of OX 19+ splenic lymphocytes. OX 19-injected animals, however, did not reveal significant reductions of W3/13 + and W3/25 + cells, raising the possibility that OX19 mAb injections may have resulted in clearance of splenic T lymphocytes as well as modulation of OX 19 membrane antigens from surviving splenic T cells. Injections of TCS containing OX8 mAb selectively and significantly reduced the percentage of OX8 + splenic lymphocytes, without a detectable effect on other subsets . None of the TCS containing mAb against the helper/inducer T cells and la' and B cell subsets showed measurable effects on splenic W3/25 + or other lymphocyte subsets (Table II) . Similarly, the RPMI-injected rats and animals injected with 3JP mAb revealed no alterations in spleen cell subsets (data not shown) .
To evaluate the possibility that OX 19 TCS injections resulted in both a reduction of T cell numbers as well as the modulation of specific antigens from the target cell surface membranes, two-color flow cytometry analyses were performed to compare the frequency of PBL staining with the noncompeting pan-T cell mAbs OX52 and OX 19 . OX52 and OX 19 react with distinct proteins on the cell surface membranes of all rat peripheral T cells (21, 23) . The data contained in Table III and illustrated in Fig. 1 B indicate that all PBL of untreated diabetes-prone rats stained after incubation with OX52 were also stained after a secondary incubation with OX 19 . protection against diabetes (p < 0 .01) (Table IV) . Injections with OX38, 0X6, or 3JP did not protect against diabetes, even when the data were statistically examined without BFA. Another parameter of protection was revealed when the pancreatic islets of the autopsied rats were examined histologically . The diabetic members of each treatment group could not be differentiated : all revealed marked insulitis with extensive loss of /3 cells and end-stage islets . Histologically, the islets of the nondiabetic rats were not uniform. None of the 43 normoglycemic OX19-treated rats, and 44 of 57 (77%) normoglycemic OX8-treated rats revealed lymphocytic insulitis (Table V) . The frequency of insulitis among nondiabetic animals of each of the other treatment groups tended to be greater than the incidence of diabetes . The numbers of animals in these groups were relatively small, and the frequencies of insulitis were not significantly different. A third measure of protection became evident when the incidence of lymphocytic thyroiditis was evaluated among nondiabetic rats . Only the OX 19 treatment group was protected against thyroiditis (Table V) The incidence of diabetes, insulitis, and thyroiditis were the same among animals killed after 14 wk, the last week of TCS injections, and after 18 wk, 4 wk after the end of mAb treatment (data not shown) . A final parameter of immunologic intervention was demonstrated when the sera of untreated, OX8-and OX 19-injected animals were examined for anti-thyroid colloid and -smooth muscle antibodies . While OX 19 TCS reduced the frequency of autoantibodypositive sera from 60 to 9% (p < 0.03), OX8 injections appeared to increase both the frequency and intensity of autoantibodies (Table VI) .
OXS Depletion of NK Cells. The absence of the OX19 + , OX8+ T cytotoxic/suppressor cell population in diabetes-prone BB/Wor rats, and the fact that virtually all OX8+ cells in these animals are NK cells (26, 32) led us to examine the effects of OX 8 and OX 19 TCS injections on functional NK activity . Splenocytes of untreated normoglycemic DB-PRN animals and nondiabetic rats treated with OX8 or OX 19 TCS for 10-14 wk were tested against NK-sensitive YAC-1 target cells in a "Cr-release assay . Splenic mononuclear leukocytes isolated from untreated DB-PRN rats had high NK lytic activity, and mediated 30-50% killing of YAC-1 target cells at E/T ratios of 200:1 (Fig. 2, DB-PRN) . Splenic mononuclear leukocytes isolated from OX8-treated animals were dramatically reduced in NK lytic activity and mediated only 10-15% lysis of YAC-1 target cells under similar conditions (Fig . 2, OX8-treated DB-PRN) . DB-RES W-line animals are inherently low in the proportion of NK cells and NK cell function (33) , and NK cell activity mediated by splenic cells isolated from the OX8-treated DB-PRN animals was comparable to that mediated by cells isolated from the DB-RES rats (Fig . 2) . Under conditions wherein splenic effector cells isolated from pooled and individual untreated DB-PRN rats in six different experiments had a geometric mean lysis of 29%, splenic cells isolated from OX8-treated rats had a geometric mean lysis of 11 % . The difference between the two groups was highly significant (p < 0.001). In contrast, injections of OX 19 TCS had no significant effect on NK cell activity (Fig . 3) . (OX8+) will achieve stable reductions of the respective lymphocyte subsets and provide profound (OX8) or complete (OX 19) protection against BB/Wor diabetes. Although it is unambiguous that OX8 injections selectively reduced only the frequency of OX8+ cells (i.e ., NK cells) in diabetes-prone BB/Wor rats, the results of OX19 injections require further analysis. The splenic lymphocytes of OX 19-treated animals studied with the technique of single-color flow cytometry revealed (Table II) markedly reduced numbers of OX 19+ cells, but only marginal reductions of helper (W3/25+) and W3/13+ cells. In contrast, PBL of a subsequent group of OX 19-treated animals studied by two-color flow cytometry revealed profound reductions of both OX52 +, OX19+ (pan-T) and OX8-, OX 19+ (helper) cells . Since the absolute number and staining intensity of W3/25' helper/inducer lymphocytes are markedly reduced in DB-PRN animals, these cells are technically difficult to quantify with accuracy using single-color flow cytometry . We have observed that this subset of T cells is more accurately counted by two-color flow cytometry after sequential incubation with OX8 and OX 19, both of which result in staining of greater intensity. Furthermore, the interpretation of data concerning W3/13+ and W3/25+ cells derived from spleen cell suspensions may be complicated by the presence of plasma cells and NK cells FIGURE 3 . Specificity of OX8 treatments for depletion of NK cell activity . NK cell activity mediated by spleen cells isolated from untreated DP-PRN, DP-RES, OX8-treated DP-PRN, and OX19-treated DP-PRN rats was examined in 5-7-h "Cr-release assays against YAC-1 target cells. Results shown were obtained with cells isolated from individual animals in five different experiments (O, 0, p, /, A) and cells pooled from two animals in one experiment (A). The E/T ratio was the same for all samples tested on a given day, and were as follows: O, 50 :1 ; ", 50:1 ; 0, 33 :1 ; ", 100 :1 ; A, 50 :1 ; A, 100:1 . Bars represent geometric means. The statistical significances of the differences between experimental groups, and untreated DB-PRN were : DB-RES p < 0 .001 ; OX 8-treated DB-PRN p < 0.001 ; OX 19-treated DP-PRN, p > 0. 5 . that are W3/13+ (21) , and by the presence of macrophages, which express W3/25 antigens (22) . The technique of two-color flow cytometry using peripheral blood leukocytes is therefore a more precise method of delineating T cell subsets in DB-PRN rats . We are therefore convinced that the reduced numbers of helper/inducer cells in OX 19-treated rats illustrated in Fig. 1 and Table III are correct, and that OX 19 treatment of DB-PRN rats in fact reduced the number of W3/25' T lymphocytes.
The results reported above also indicate that injections of OX8 profoundly protected and injections of OX 19 TCS completely protected against diabetes . Furthermore, although a substantial number of nondiabetic OX8-treated animals showed signs of lymphocytic insulitis, this was not observed after OX 19 injections . We interpret these results to indicate a role for both NK cells and helper/inducer cells in the pathogenesis of BB diabetes .
The evidence that OX8 TCS injections reduced OX8+ cell numbers is supported by the in vitro NK assays . The reduction of phenotypic NK cells (OX8 +, OX 19-by flow cytometry) (Table 111 ) correlated with a significant reduction in the lysis of YAC-1 cells in vitro (Figs. 2 and 3 ). The evidence indicating that NK cells contribute to the induction of diabetes in the DB-PRN rat is now very persuasive . Both NK cell numbers and activity are elevated on a per-cell basis in untreated DB-PRN as compared to DP-RES rats (Fig. 2) (33) . Data reported previously (19) indicate that 0X8+ cells are localized at the site of the insulitis lesion in the BB/Wor rat. The data presented here indicate that injections of OX8 mAb prevented diabetes and also resulted in the clearing of 0X8+ cells from the spleen (Table II) and blood (Table III) . Since virtually all of the 0X8+ cells in DB-PRN rats belong to the NK cell subset (26) , and since OX8 injections both prevented diabetes and depleted NK cell activity (Figs. 2 and 3) , we believe that NK cells contribute to the mechanism of (3 cell destruction . Although we can not exclude the possibility that another 0X8'}, 0X19 -subset is (also) involved, this does not appear likely, since all 0X8+ cells in the DP-PRN rat are also brightly stained with a second NK cell marker, AGM I (33).
Although OX 19 injections protected against diabetes, they did not reduce the number of NK cells or NK cell-mediated lysis of YAC-1 cells. Therefore NK cells cannot be solely responsible for BB/Wor diabetes . It is reasonable therefore to suggest that the helper/inducer cell subset is required for continued (lymphokine) stimulation of NK cell activity and/or the stimulation of B lymphocyte synthesis of islet cell-surface antibodies, which may precede the temporal onset of diabetes in the BB rat (8) . Indirect support for the latter possibility is derived from the evidence that autoantibodies directed against smooth muscle and thyroid colloid were significantly reduced in OX 19-injected rats (Table IV) .
An alternate explanation for the reduction of autoantibody synthesis in OX 19-treated rats is suggested by the reported (34) presence of a small subset of B lymphocytes that bear the Ly-1 phenotype and are capable of synthesizing autoantibodies in normal and immunodeficient mice . OX 19 is thought to be the analog of murine Ly-1 in the rat. To date, no such 0X19+ B cell subset has been described . If, however, a comparable OX 19 + B cell subset exists in the immunodeficient BB/Wor rat, it is possible that the protective effects of OX 19 treatment could be due in part to a direct effect on these B lymphocytes.
Injections of TCS containing mAb that bind selectively to helper/inducer cells (W3/25, 0X35, and 0X38) and to cells with class II (Ia) surface membrane antigens (0X6, 3JP, and OX 17) did not reduce the percentages of helper or Ia+ splenic cell subsets. This was noted even after injections of mAb of the IgG2a class (0X35, 0X38, and 3JP) . The results reported above indicate that marginal reductions in the frequency of diabetes were realized in W3/25-and 0X35 TCS-treated animals without reduced helper cell numbers. Furthermore, normoglycemic recipients of anti-helper/inducer cell mAb did not reveal reduced frequencies of insulitis. It is not known whether prolonged injections of larger quantities of mAb would have reduced the number of W3/25+ cells and protected more profoundly against diabetes (and insulitis) . Injections of 6 mg of W3/25 ascites mAb to each of 10 diabetes-prone rats over a 3-wk interval neither reduced splenic W3/25+ cells nor prevented diabetes (data not illustrated) .
Brostoff and Mason (35) have reported the reduction in duration and amelioration of severity of experimental allergic encephalomyelitis (EAE) in Lewis rats after injections of milligram quantities of W3/25 without associated reductions of circulating T helper cells. Those workers speculated that the injected mAb might impair helper cell function without cell loss . In confirmation of Brostoff's observations was the report that injections of anti-helper cell (L3T4) mAb prevented and ameliorated EAE in mice (36) . Anti-L3T4 mAb also reduced the severity of the autoimmune syndrome in NZB/NZW F, mice (37) . In both groups of mouse experiments, mAb treatment reduced circulating L3T4 cells.
The marginal protection against diabetes that followed injections of OX 17 (IaE) but not OX6 or 3JP (IaA) confirms the published report of Boitard, et al . (38) . Those investigators reported that injections of purified anti-IaE mAb provided marginal protection against BB/Wor diabetes and lymphocytic thyroiditis, when considered individually . Protection, however, reached statistical significance only when the frequency of diabetes and thyroiditis were combined . Boitard et al . did not report the effects of their treatments on lymphocyte subsets.
Finally, we note with interest that there was an unanticipated relationship between the IgG class of the injected mAb and the reduction of T cell subsets. Hence, OX8 and OX 19, both IgG1 isotypes, induced profound reductions of PBL and splenocyte subsets, and protected against diabetes . OX35, OX38, and 3JP are all IgG2a isotypes, and in the quantities injected did not reduce the number of their respective subsets. This contrasts with the report of Cobbold et al . (39) , wherein IgG2B but not IgGI mAb was responsible for in vivo helper T cell elimination in mice .
Summary
Diabetes-prone BioBreeding/Worcester (BB/Wor) rats received thrice weekly injections of mAb against antigens expressed on the surface of all T cells (OX19), cytotoxic/suppressor, and NK cells (OX8), helper/inducer cells (W3/25, OX35, OX38), and Ia+ cells (OX6, 3JP, OX 17). Treatment with OX8 or OX 19 achieved stable reductions of splenic and peripheral blood NK cells and helper/inducer T lymphocytes, respectively, and protected against diabetes . OX 19 injections also prevented lymphocytic insulitis, thyroiditis, and the synthesis of autoantibodies to thyroid colloid and smooth muscle antigens. OX8 injections reduced splenic NK-mediated YAC-1 cell lysis, but did not prevent insulitis, thyroiditis, or autoantibody synthesis. Injections of mAb specific for antigens on the surface of helper/inducer cells, and for cells expressing IaE antigens provided marginal protection against diabetes without reductions of phenotypic subsets. These findings suggest that pancreatic a cell destruction in the spontaneously diabetic BB/Wor rat is mediated by the combined action of NK and helper/inducer cells.
